BOSTON SCIENTIFIC CORP (1BSX.MI) Stock Fundamental Analysis
BIT:1BSX - Euronext Milan - US1011371077 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to 1BSX. 1BSX was compared to 59 industry peers in the Health Care Equipment & Supplies industry. 1BSX scores excellent on profitability, but there are some minor concerns on its financial health. 1BSX is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year 1BSX was profitable.
In the past year 1BSX had a positive cash flow from operations.
1BSX had positive earnings in 4 of the past 5 years.
In the past 5 years 1BSX always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 5.06%, 1BSX is doing good in the industry, outperforming 71.19% of the companies in the same industry.
With a decent Return On Equity value of 9.15%, 1BSX is doing good in the industry, outperforming 66.10% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.60%, 1BSX is doing good in the industry, outperforming 72.88% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1BSX is in line with the industry average of 8.10%.
The 3 year average ROIC (6.54%) for 1BSX is below the current ROIC(7.60%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.06% | ||
| ROE | 9.15% | ||
| ROIC | 7.6% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
1.3 Margins
With a decent Profit Margin value of 11.58%, 1BSX is doing good in the industry, outperforming 76.27% of the companies in the same industry.
In the last couple of years the Profit Margin of 1BSX has declined.
Looking at the Operating Margin, with a value of 18.85%, 1BSX belongs to the top of the industry, outperforming 81.36% of the companies in the same industry.
In the last couple of years the Operating Margin of 1BSX has remained more or less at the same level.
Looking at the Gross Margin, with a value of 68.73%, 1BSX is in the better half of the industry, outperforming 74.58% of the companies in the same industry.
1BSX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 11.58% | ||
| GM | 68.73% |
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1BSX is destroying value.
The number of shares outstanding for 1BSX has been increased compared to 1 year ago.
The number of shares outstanding for 1BSX has been increased compared to 5 years ago.
The debt/assets ratio for 1BSX is higher compared to a year ago.
2.2 Solvency
1BSX has an Altman-Z score of 6.17. This indicates that 1BSX is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.17, 1BSX belongs to the best of the industry, outperforming 93.22% of the companies in the same industry.
The Debt to FCF ratio of 1BSX is 3.75, which is a good value as it means it would take 1BSX, 3.75 years of fcf income to pay off all of its debts.
1BSX has a better Debt to FCF ratio (3.75) than 72.88% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that 1BSX is not too dependend on debt financing.
1BSX's Debt to Equity ratio of 0.47 is in line compared to the rest of the industry. 1BSX outperforms 45.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.75 | ||
| Altman-Z | 6.17 |
ROIC/WACC0.9
WACC8.44%
2.3 Liquidity
A Current Ratio of 1.45 indicates that 1BSX should not have too much problems paying its short term obligations.
1BSX has a Current ratio (1.45) which is comparable to the rest of the industry.
A Quick Ratio of 0.88 indicates that 1BSX may have some problems paying its short term obligations.
The Quick ratio of 1BSX (0.88) is worse than 64.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.45 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
1BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.91%, which is quite impressive.
Measured over the past years, 1BSX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.56% on average per year.
Looking at the last year, 1BSX shows a very strong growth in Revenue. The Revenue has grown by 21.45%.
The Revenue has been growing by 9.30% on average over the past years. This is quite good.
EPS 1Y (TTM)26.91%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%20.97%
Revenue 1Y (TTM)21.45%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%22.84%
3.2 Future
1BSX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.43% yearly.
The Revenue is expected to grow by 10.66% on average over the next years. This is quite good.
EPS Next Y17.44%
EPS Next 2Y15.26%
EPS Next 3Y14.33%
EPS Next 5Y12.43%
Revenue Next Year19.33%
Revenue Next 2Y15.03%
Revenue Next 3Y13.34%
Revenue Next 5Y10.66%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 37.70 indicates a quite expensive valuation of 1BSX.
Compared to the rest of the industry, the Price/Earnings ratio of 1BSX is on the same level as its industry peers.
1BSX is valuated rather expensively when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 31.98, the valuation of 1BSX can be described as expensive.
1BSX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1BSX is more expensive than 62.71% of the companies in the same industry.
1BSX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 34.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.7 | ||
| Fwd PE | 31.98 |
4.2 Price Multiples
64.41% of the companies in the same industry are cheaper than 1BSX, based on the Enterprise Value to EBITDA ratio.
1BSX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 52.35 | ||
| EV/EBITDA | 36.62 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1BSX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1BSX may justify a higher PE ratio.
A more expensive valuation may be justified as 1BSX's earnings are expected to grow with 14.33% in the coming years.
PEG (NY)2.16
PEG (5Y)3.94
EPS Next 2Y15.26%
EPS Next 3Y14.33%
5. Dividend
5.1 Amount
1BSX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1BSX (7/28/2025, 7:00:00 PM)
91.6
+3.2 (+3.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners93.45%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap135.52B
Analysts85
Price Target107.18 (17.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.08%
Min EPS beat(2)5.6%
Max EPS beat(2)10.56%
EPS beat(4)4
Avg EPS beat(4)7.06%
Min EPS beat(4)5.6%
Max EPS beat(4)10.56%
EPS beat(8)8
Avg EPS beat(8)6.71%
EPS beat(12)11
Avg EPS beat(12)5.15%
EPS beat(16)15
Avg EPS beat(16)4.51%
Revenue beat(2)2
Avg Revenue beat(2)1.51%
Min Revenue beat(2)0.97%
Max Revenue beat(2)2.04%
Revenue beat(4)4
Avg Revenue beat(4)1.92%
Min Revenue beat(4)0.97%
Max Revenue beat(4)3.16%
Revenue beat(8)8
Avg Revenue beat(8)2.02%
Revenue beat(12)10
Avg Revenue beat(12)1.79%
Revenue beat(16)12
Avg Revenue beat(16)1.49%
PT rev (1m)-0.43%
PT rev (3m)-4.59%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)2.58%
EPS NY rev (1m)0.15%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)2.51%
Revenue NY rev (1m)1.63%
Revenue NY rev (3m)3.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.7 | ||
| Fwd PE | 31.98 | ||
| P/S | 8.99 | ||
| P/FCF | 52.35 | ||
| P/OCF | 41.39 | ||
| P/B | 7.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 36.62 |
EPS(TTM)2.43
EY2.65%
EPS(NY)2.86
Fwd EY3.13%
FCF(TTM)1.75
FCFY1.91%
OCF(TTM)2.21
OCFY2.42%
SpS10.19
BVpS12.9
TBVpS-0.98
PEG (NY)2.16
PEG (5Y)3.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.06% | ||
| ROE | 9.15% | ||
| ROCE | 9.43% | ||
| ROIC | 7.6% | ||
| ROICexc | 7.76% | ||
| ROICexgc | 25.5% | ||
| OM | 18.85% | ||
| PM (TTM) | 11.58% | ||
| GM | 68.73% | ||
| FCFM | 17.17% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.54%
ROIC(5y)5.68%
ROICexc(3y)6.7%
ROICexc(5y)5.9%
ROICexgc(3y)22.68%
ROICexgc(5y)19.43%
ROCE(3y)8.12%
ROCE(5y)7.05%
ROICexcg growth 3Y8.56%
ROICexcg growth 5Y6.81%
ROICexc growth 3Y4.36%
ROICexc growth 5Y5.23%
OM growth 3Y0.33%
OM growth 5Y1.13%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.3%
GM growth 5Y-0.65%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 3.75 | ||
| Debt/EBITDA | 2.29 | ||
| Cap/Depr | 61.86% | ||
| Cap/Sales | 4.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 82.91% | ||
| Profit Quality | 148.33% | ||
| Current Ratio | 1.45 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 6.17 |
F-Score5
WACC8.44%
ROIC/WACC0.9
Cap/Depr(3y)57.82%
Cap/Depr(5y)54.13%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.85%
Profit Quality(3y)134.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.91%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%20.97%
EPS Next Y17.44%
EPS Next 2Y15.26%
EPS Next 3Y14.33%
EPS Next 5Y12.43%
Revenue 1Y (TTM)21.45%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%22.84%
Revenue Next Year19.33%
Revenue Next 2Y15.03%
Revenue Next 3Y13.34%
Revenue Next 5Y10.66%
EBIT growth 1Y30.65%
EBIT growth 3Y12.47%
EBIT growth 5Y10.54%
EBIT Next Year32.67%
EBIT Next 3Y19.08%
EBIT Next 5Y13.71%
FCF growth 1Y151.8%
FCF growth 3Y26.15%
FCF growth 5Y16.61%
OCF growth 1Y114.76%
OCF growth 3Y22.44%
OCF growth 5Y13.34%